Literature DB >> 19217813

A point mutation in the neu1 promoter recruits an ectopic repressor, Nkx3.2 and results in a mouse model of sialidase deficiency.

Marc J Champigny1, Mark Mitchell, Alison Fox-Robichaud, Bernardo L Trigatti, Suleiman A Igdoura.   

Abstract

SM/J is an inbred mouse strain with a complex phenotype including small body size, impaired immune response and a tissue-specific sialidase deficiency. We identified a regulatory mutation, (-519G-->A) within the neu1 promoter which in reporter assays resulted in significantly reduced transcription. This mutation generates a consensus binding site for Nkx3 family transcription repressors. Recombinant Nkx3.2 bound strongly to and preferentially repressed transcription of the mutant promoter. This tissue-specific deficiency results in a retarded immune response and modulates leukocyte recruitment. Examination of the hepatic microcirculation in mutant mice revealed increased rolling and decreased adhesion of leukocytes. Our findings support a significant role for lysosomal sialidase in inflammation and highlight the significance of repressor-recruitment in genetic disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19217813     DOI: 10.1016/j.ymgme.2009.01.004

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  7 in total

1.  Sialidase down-regulation reduces non-HDL cholesterol, inhibits leukocyte transmigration, and attenuates atherosclerosis in ApoE knockout mice.

Authors:  Elizabeth J White; Gabriel Gyulay; Šárka Lhoták; Magdalena M Szewczyk; Taryne Chong; Mark T Fuller; Omid Dadoo; Alison E Fox-Robichaud; Richard C Austin; Bernardo L Trigatti; Suleiman A Igdoura
Journal:  J Biol Chem       Date:  2018-08-10       Impact factor: 5.157

Review 2.  Where catabolism meets signalling: neuraminidase 1 as a modulator of cell receptors.

Authors:  Alexey V Pshezhetsky; Aleksander Hinek
Journal:  Glycoconj J       Date:  2011-09-20       Impact factor: 2.916

3.  QTLs for murine red blood cell parameters in LG/J and SM/J F(2) and advanced intercross lines.

Authors:  Thomas B Bartnikas; Clarissa C Parker; Riyan Cheng; Dean R Campagna; Jackie E Lim; Abraham A Palmer; Mark D Fleming
Journal:  Mamm Genome       Date:  2012-02-10       Impact factor: 2.957

4.  Hypomorphic sialidase expression decreases serum cholesterol by downregulation of VLDL production in mice.

Authors:  Abraham Yang; Gabriel Gyulay; Mark Mitchell; Elizabeth White; Bernardo L Trigatti; Suleiman A Igdoura
Journal:  J Lipid Res       Date:  2012-09-14       Impact factor: 5.922

Review 5.  Lipoprotein sialylation in atherosclerosis: Lessons from mice.

Authors:  Liming Yu; Jun Peng; Chieko Mineo
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-06       Impact factor: 6.055

6.  Implications for the mammalian sialidases in the physiopathology of skeletal muscle.

Authors:  Alessandro Fanzani; Alessandra Zanola; Fiorella Faggi; Nadia Papini; Bruno Venerando; Guido Tettamanti; Maurilio Sampaolesi; Eugenio Monti
Journal:  Skelet Muscle       Date:  2012-11-01       Impact factor: 4.912

7.  Neuraminidase-1 promotes heart failure after ischemia/reperfusion injury by affecting cardiomyocytes and invading monocytes/macrophages.

Authors:  Maren Heimerl; Irina Sieve; Melanie Ricke-Hoch; Sergej Erschow; Karin Battmer; Michaela Scherr; Denise Hilfiker-Kleiner
Journal:  Basic Res Cardiol       Date:  2020-09-25       Impact factor: 17.165

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.